Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 22.32 % |
3 Month Return | -13.64 % |
1 Year Return | + 2.52 % |
Market Stats | |
Previous Close | ₹110.00 |
Open | ₹111.05 |
Volume | 9,309.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹649.96Cr |
P/E Ratio | 1.74 |
PEG Ratio | 0.03 |
Market Cap | ₹649.96 Cr |
P/B Ratio | 0.63 |
EPS | 71.33 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 18.99 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹649.96 Cr | 72.05% | 0.51 | ₹421 Cr | ₹1,280 Cr | |
NA | ₹2,082.43 Cr | 12.22% | 0.51 | NA | NA | |
NA | ₹59.40 Cr | 36.86% | 0.72 | -₹11 Cr | ₹146 Cr | |
NA | ₹484.29 Cr | -6.91% | 0.60 | ₹29 Cr | ₹182 Cr | |
NA | ₹2,172.85 Cr | 98.15% | 0.67 | ₹49 Cr | ₹709 Cr |
Organisation | Ind-Swift Laboratories Ltd |
Headquarters | Chandigarh |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Ind-Swift Laboratories Ltd
Ind-Swift Laboratories Ltd Stock Up 296% in Five Years - 29 Jun, 2024
Ind-Swift Laboratories to Raise Funds Through Issuance of Instruments - 25 Jun, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, INDSWFTLAB stock has moved up by 22.3%
Retail Holding Up
Retail Investor have increased holdings from 56.21% to 56.41% in Sep 2024 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 50.7% return, outperforming this stock by 48.2%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 122.6% return, outperforming this stock by 75.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 42.00% of holdings in Sep 2024 quarter
Revenue Fall
Revenue is down for the last 3 quarters, 805.18 Cr → 24.96 Cr (in ₹), with an average decrease of 69.1% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 0.85% to 0.65% in Sep 2024 quarter
Profit Down
Netprofit is down for the last 3 quarters, 352.64 Cr → 0.41 Cr (in ₹), with an average decrease of 78.1% per quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 42% | 0.00 | |
Foreign Institutions | 0.65% | ||
Mutual Funds | 0% | 0.00 | |
Retail Investors | 56.41% | 0.35 | |
Others | 0.94% | 0.00 |
Ind-Swift Laboratories Ltd in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (1.74x)
January 1, 2025
Industry (58.41x)
January 1, 2025
Highest (64.97x)
July 19, 2021
Ind-Swift Laboratories Ltd’s net profit fell -98.7% since last year same period to ₹0.41Cr in the Q2 2024-2025. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -56.38% fall in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Ind-Swift Laboratories Ltd is currently in a Bullish trading position according to technical analysis indicators.
Ind-Swift Laboratories Ltd (INDSWFTLAB) share price today is ₹111.05
Ind-Swift Laboratories Ltd is listed on NSE
Ind-Swift Laboratories Ltd is listed on BSE
PE Ratio of Ind-Swift Laboratories Ltd is 1.74
PE ratio = Ind-Swift Laboratories Ltd Market price per share / Ind-Swift Laboratories Ltd Earnings per share
Today’s traded volume of Ind-Swift Laboratories Ltd(INDSWFTLAB) is 9,309.00.
Today’s market capitalisation of Ind-Swift Laboratories Ltd(INDSWFTLAB) is ₹649.96Cr.
Ind-Swift Laboratories Ltd(INDSWFTLAB | Price |
---|---|
52 Week High | ₹186 |
52 Week Low | ₹86.2 |
Ind-Swift Laboratories Ltd(INDSWFTLAB) share price is ₹111.05. It is down -40.30% from its 52 Week High price of ₹186
Ind-Swift Laboratories Ltd(INDSWFTLAB) share price is ₹111.05. It is up 28.83% from its 52 Week Low price of ₹86.2
Ind-Swift Laboratories Ltd(INDSWFTLAB | Returns |
---|---|
1 Day Returns | 1.05% |
1 Month Returns | 22.32% |
3 Month Returns | -13.64% |
1 Year Returns | 2.52% |